• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接种新冠疫苗(辉瑞,BNT162b2)后发生肺栓塞:一例报告

Pulmonary Embolism after Vaccination with the COVID-19 Vaccine (Pfizer, BNT162b2): A Case Report.

作者信息

Kim Eun-Ju, Yoo Seok-Ju

机构信息

Department of Infectious Disease Control, Ulsan Metropolitan City Hall, Ulsan 44675, Republic of Korea.

Department of Preventive Medicine, College of Medicine, Dongguk University, Gyeongju 38066, Republic of Korea.

出版信息

Vaccines (Basel). 2023 Jun 7;11(6):1075. doi: 10.3390/vaccines11061075.

DOI:10.3390/vaccines11061075
PMID:37376463
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10303489/
Abstract

Pulmonary embolism causes pulmonary vascular obstruction and damages circulation, leading to death in serious cases. Various cases of thrombosis have been reported as adverse reactions after vaccination with COVID-19 vaccines, and reliable studies on thrombosis with thrombocytopenia syndrome (TTS) have been confirmed, especially for viral vector vaccines. However, the association with mRNA vaccines has not been proven. We report a case of pulmonary embolism and deep vein thrombosis that occurred after using mRNA COVID-19 vaccines (BNT162b2).

摘要

肺栓塞会导致肺血管阻塞并损害循环系统,严重时可导致死亡。已有多例接种新冠疫苗后出现血栓形成的不良反应报告,并且关于血栓形成伴血小板减少综合征(TTS)的可靠研究已得到证实,尤其是对于病毒载体疫苗。然而,与mRNA疫苗的关联尚未得到证实。我们报告一例使用mRNA新冠疫苗(BNT162b2)后发生肺栓塞和深静脉血栓形成的病例。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6700/10303489/b21fb1dc4af8/vaccines-11-01075-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6700/10303489/c0c5e5c06d75/vaccines-11-01075-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6700/10303489/b21fb1dc4af8/vaccines-11-01075-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6700/10303489/c0c5e5c06d75/vaccines-11-01075-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6700/10303489/b21fb1dc4af8/vaccines-11-01075-g002.jpg

相似文献

1
Pulmonary Embolism after Vaccination with the COVID-19 Vaccine (Pfizer, BNT162b2): A Case Report.接种新冠疫苗(辉瑞,BNT162b2)后发生肺栓塞:一例报告
Vaccines (Basel). 2023 Jun 7;11(6):1075. doi: 10.3390/vaccines11061075.
2
Case Series of Thrombosis With Thrombocytopenia Syndrome After COVID-19 Vaccination-United States, December 2020 to August 2021.2020 年 12 月至 2021 年 8 月美国 COVID-19 疫苗接种后血栓性血小板减少综合征病例系列报告。
Ann Intern Med. 2022 Apr;175(4):513-522. doi: 10.7326/M21-4502. Epub 2022 Jan 18.
3
Extensive Cerebral Venous Sinus Thrombosis (CVST) After the First Dose of Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine without Thrombotic Thrombocytopenia Syndrome (TTS) in a Healthy Woman.健康女性在接种第一剂辉瑞-生物科技 BNT162b2 mRNA COVID-19 疫苗后发生广泛脑静脉窦血栓形成(CVST),但无血栓性血小板减少综合征(TTS)。
Am J Case Rep. 2022 Feb 9;23:e934744. doi: 10.12659/AJCR.934744.
4
A 59-Year-Old Woman with Extensive Deep Vein Thrombosis and Pulmonary Thromboembolism 7 Days Following a First Dose of the Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine.一位 59 岁女性,在接种第一剂辉瑞-生物科技 BNT162b2 mRNA COVID-19 疫苗后 7 天出现广泛的深静脉血栓形成和肺血栓栓塞症。
Am J Case Rep. 2021 Jun 12;22:e932946. doi: 10.12659/AJCR.932946.
5
Association of AZD1222 and BNT162b2 COVID-19 Vaccination With Thromboembolic and Thrombocytopenic Events in Frontline Personnel : A Retrospective Cohort Study.AZD1222 和 BNT162b2 新冠疫苗接种与一线人员血栓栓塞和血小板减少事件的关联:一项回顾性队列研究。
Ann Intern Med. 2022 Apr;175(4):541-546. doi: 10.7326/M21-2452. Epub 2022 Feb 1.
6
Immune thrombocytopenia following immunisation with Vaxzevria ChadOx1-S (AstraZeneca) vaccine, Victoria, Australia.在接种 Vaxzevria ChadOx1-S(阿斯利康)疫苗后发生免疫性血小板减少症,澳大利亚维多利亚州。
Vaccine. 2021 Nov 26;39(48):7052-7057. doi: 10.1016/j.vaccine.2021.10.030. Epub 2021 Oct 30.
7
Surveillance for Adverse Events After COVID-19 mRNA Vaccination.COVID-19 mRNA 疫苗接种后不良事件的监测。
JAMA. 2021 Oct 12;326(14):1390-1399. doi: 10.1001/jama.2021.15072.
8
Comparative risk of thrombosis with thrombocytopenia syndrome or thromboembolic events associated with different covid-19 vaccines: international network cohort study from five European countries and the US.不同 COVID-19 疫苗相关的血栓性血小板减少综合征或血栓栓塞事件的比较风险:来自五个欧洲国家和美国的国际网络队列研究。
BMJ. 2022 Oct 26;379:e071594. doi: 10.1136/bmj-2022-071594.
9
Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021.在报告 Janssen(强生)和 mRNA COVID-19 疫苗(辉瑞-生物科技和莫德纳)成年受种者发生不良事件后使用 COVID-19 疫苗:免疫实践咨询委员会的更新-美国,2021 年 7 月。
MMWR Morb Mortal Wkly Rep. 2021 Aug 13;70(32):1094-1099. doi: 10.15585/mmwr.mm7032e4.
10
[A rare case of myocarditis and pulmonary embolism after BNT162b2 mRNA vaccine].[BNT162b2 mRNA疫苗接种后发生心肌炎和肺栓塞的罕见病例]
G Ital Cardiol (Rome). 2022 Apr;23(4):244-246. doi: 10.1714/3766.37531.

引用本文的文献

1
Cardiopulmonary Effects of COVID-19 Vaccination: A Comprehensive Narrative Review.新冠疫苗接种的心肺效应:一篇全面的叙述性综述
Vaccines (Basel). 2025 May 22;13(6):548. doi: 10.3390/vaccines13060548.
2
SARS-CoV-2 Vaccine Improved Hemostasis of a Patient with Protein S Deficiency: A Case Report.SARS-CoV-2 疫苗改善了蛋白 S 缺乏症患者的止血功能:一例报告。
Int J Mol Sci. 2024 Oct 5;25(19):10717. doi: 10.3390/ijms251910717.
3
Determinants of COVID-19 vaccine-induced myocarditis.新冠病毒疫苗诱导的心肌炎的决定因素。

本文引用的文献

1
COVID-19 Vaccination in Korea.韩国的新冠疫苗接种情况。
Infect Chemother. 2023 Mar;55(1):135-149. doi: 10.3947/ic.2023.0023.
2
Acute pulmonary thromboembolism after messenger RNA vaccination against coronavirus disease 2019: A case report.2019冠状病毒病信使核糖核酸疫苗接种后急性肺血栓栓塞症:一例报告
J Cardiol Cases. 2023 Jun;27(6):266-270. doi: 10.1016/j.jccase.2023.02.014. Epub 2023 Feb 20.
3
COVID-19 Vaccination Associated Bilateral Pulmonary Embolism: Cause or Coincidence.新冠病毒疫苗接种相关的双侧肺栓塞:是原因还是巧合。
Ther Adv Drug Saf. 2024 Jan 27;15:20420986241226566. doi: 10.1177/20420986241226566. eCollection 2024.
4
Blood Coagulation and Thrombotic Disorders following SARS-CoV-2 Infection and COVID-19 Vaccination.新型冠状病毒2感染和新冠疫苗接种后的血液凝固及血栓形成障碍
Biomedicines. 2023 Oct 17;11(10):2813. doi: 10.3390/biomedicines11102813.
Case Rep Pulmonol. 2022 Sep 29;2022:9596285. doi: 10.1155/2022/9596285. eCollection 2022.
4
Acute Pulmonary Embolism Following Moderna mRNA-1273 SARS-CoV-2 Vaccination - A Case Report and Literature Review.Moderna mRNA-1273新型冠状病毒疫苗接种后发生急性肺栓塞——病例报告及文献综述
Acta Cardiol Sin. 2022 Jul;38(4):539-541. doi: 10.6515/ACS.202207_38(4).20220121B.
5
Pulmonary embolism with junctional tachycardia: A serious complication after COVID-19 vaccination.伴有交界性心动过速的肺栓塞:新冠病毒疫苗接种后的一种严重并发症。
Ann Med Surg (Lond). 2022 Aug;80:103983. doi: 10.1016/j.amsu.2022.103983. Epub 2022 Jun 28.
6
Incidence of Venous Thromboembolism: The 3 Korean Nationwide Study.静脉血栓栓塞症的发病率:三项韩国全国性研究
J Korean Med Sci. 2022 May 2;37(17):e130. doi: 10.3346/jkms.2022.37.e130.
7
Association of COVID-19 vaccines ChAdOx1 and BNT162b2 with major venous, arterial, or thrombocytopenic events: A population-based cohort study of 46 million adults in England.COVID-19 疫苗 ChAdOx1 和 BNT162b2 与主要静脉、动脉或血小板减少性事件的关联:一项基于英格兰 4600 万成年人的基于人群的队列研究。
PLoS Med. 2022 Feb 22;19(2):e1003926. doi: 10.1371/journal.pmed.1003926. eCollection 2022 Feb.
8
Thrombotic events and COVID-19 vaccines.血栓事件与 COVID-19 疫苗。
Int J Tuberc Lung Dis. 2021 Sep 1;25(9):701-707. doi: 10.5588/ijtld.21.0298.
9
Case Report: Vaccine-Induced Immune Thrombotic Thrombocytopenia in a Pancreatic Cancer Patient After Vaccination With Messenger RNA-1273.病例报告:一名胰腺癌患者接种信使核糖核酸-1273疫苗后发生疫苗诱导的免疫性血栓性血小板减少症。
Front Med (Lausanne). 2021 Nov 1;8:772424. doi: 10.3389/fmed.2021.772424. eCollection 2021.
10
A Case of Acute Pulmonary Embolus after mRNA SARS-CoV-2 Immunization.1例新型冠状病毒mRNA疫苗接种后急性肺栓塞病例
Vaccines (Basel). 2021 Aug 14;9(8):903. doi: 10.3390/vaccines9080903.